2014-2023年全球麻疹、腮腺炎和风疹疫苗接种状况和发病率

IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Qianqian Liu, Qi Bi, Siyu Liu, Yuexin Xiu, Fuzhen Wang, Zundong Yin, Xiaoxue Liu
{"title":"2014-2023年全球麻疹、腮腺炎和风疹疫苗接种状况和发病率","authors":"Qianqian Liu, Qi Bi, Siyu Liu, Yuexin Xiu, Fuzhen Wang, Zundong Yin, Xiaoxue Liu","doi":"10.46234/ccdcw2025.094","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Measles, mumps, and rubella remain significant global health threats despite being vaccine-preventable diseases. The World Health Organization aims to achieve regional elimination of measles and rubella by 2030, yet substantial disparities in vaccination coverage and disease incidence persist across regions. We analyzed global vaccination and disease data to provide evidence for optimizing immunization strategies.</p><p><strong>Methods: </strong>The study analyzed World Health Organization data on measles, mumps, and rubella from 2014-2023. Our analysis included vaccine types, recommended vaccination schedules, coverage rates, supplemental immunization activities, and disease incidence. We employed descriptive epidemiological methods for data synthesis and analysis.</p><p><strong>Results: </strong>All countries implemented ≥1 measles-containing vaccine dose, with 190 (97.9%) countries using a ≥2-dose schedule. Global 2nd dose of measles-containing vaccine coverage increased from 59% to 74% during the study period. High-income regions maintained >90% coverage, while the African Region reported the lowest coverage (70% for the 1st dose and 49% for the 2nd dose of measles-containing vaccine). Supplemental immunization activities helped address coverage gaps but required integration with routine immunization systems. Rubella vaccine was implemented in 90.2% of countries, while mumps vaccine adoption remained lower at 63.9%. The African Region experienced high incidence rates for both measles (551.8 per million) and rubella (21.9 per million). The COVID-19 pandemic disrupted vaccination coverage (3%-5% decline globally), with the African Region experiencing a post-pandemic U-shaped resurgence in cases. China's transition to the measles, mumps, and rubella vaccine has reduced mumps incidence to below 100 cases per million by 2020.</p><p><strong>Conclusions: </strong>While global control of measles, mumps, and rubella has progressed, inequities in vaccination coverage and pandemic-related disruptions threaten elimination goals. Strengthening routine immunization systems is critical. Achieving the World Health Organization's 2030 targets will require sustained investment in health systems and implementation of equity-focused innovations.</p>","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"7 17","pages":"561-567"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12075482/pdf/","citationCount":"0","resultStr":"{\"title\":\"Vaccination Status and Incidences of Measles, Mumps, and Rubella - Worldwide, 2014-2023.\",\"authors\":\"Qianqian Liu, Qi Bi, Siyu Liu, Yuexin Xiu, Fuzhen Wang, Zundong Yin, Xiaoxue Liu\",\"doi\":\"10.46234/ccdcw2025.094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Measles, mumps, and rubella remain significant global health threats despite being vaccine-preventable diseases. The World Health Organization aims to achieve regional elimination of measles and rubella by 2030, yet substantial disparities in vaccination coverage and disease incidence persist across regions. We analyzed global vaccination and disease data to provide evidence for optimizing immunization strategies.</p><p><strong>Methods: </strong>The study analyzed World Health Organization data on measles, mumps, and rubella from 2014-2023. Our analysis included vaccine types, recommended vaccination schedules, coverage rates, supplemental immunization activities, and disease incidence. We employed descriptive epidemiological methods for data synthesis and analysis.</p><p><strong>Results: </strong>All countries implemented ≥1 measles-containing vaccine dose, with 190 (97.9%) countries using a ≥2-dose schedule. Global 2nd dose of measles-containing vaccine coverage increased from 59% to 74% during the study period. High-income regions maintained >90% coverage, while the African Region reported the lowest coverage (70% for the 1st dose and 49% for the 2nd dose of measles-containing vaccine). Supplemental immunization activities helped address coverage gaps but required integration with routine immunization systems. Rubella vaccine was implemented in 90.2% of countries, while mumps vaccine adoption remained lower at 63.9%. The African Region experienced high incidence rates for both measles (551.8 per million) and rubella (21.9 per million). The COVID-19 pandemic disrupted vaccination coverage (3%-5% decline globally), with the African Region experiencing a post-pandemic U-shaped resurgence in cases. China's transition to the measles, mumps, and rubella vaccine has reduced mumps incidence to below 100 cases per million by 2020.</p><p><strong>Conclusions: </strong>While global control of measles, mumps, and rubella has progressed, inequities in vaccination coverage and pandemic-related disruptions threaten elimination goals. Strengthening routine immunization systems is critical. Achieving the World Health Organization's 2030 targets will require sustained investment in health systems and implementation of equity-focused innovations.</p>\",\"PeriodicalId\":69039,\"journal\":{\"name\":\"中国疾病预防控制中心周报\",\"volume\":\"7 17\",\"pages\":\"561-567\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12075482/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国疾病预防控制中心周报\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.46234/ccdcw2025.094\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国疾病预防控制中心周报","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.46234/ccdcw2025.094","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

摘要

麻疹、腮腺炎和风疹尽管是疫苗可预防的疾病,但仍然是重大的全球健康威胁。世界卫生组织的目标是到2030年实现区域消除麻疹和风疹,但各区域在疫苗接种覆盖率和疾病发病率方面仍然存在巨大差异。我们分析了全球疫苗接种和疾病数据,为优化免疫策略提供证据。方法:该研究分析了2014-2023年世界卫生组织关于麻疹、腮腺炎和风疹的数据。我们的分析包括疫苗类型、推荐接种时间表、覆盖率、补充免疫活动和疾病发病率。我们采用描述性流行病学方法进行数据综合和分析。结果:所有国家均实施≥1剂含麻疹疫苗接种,其中190个(97.9%)国家采用≥2剂接种计划。在研究期间,全球第二剂含麻疹疫苗覆盖率从59%增加到74%。高收入区域的接种率保持在90%以上,而非洲区域报告的接种率最低(第一剂为70%,第二剂为49%)。补充免疫活动有助于弥补覆盖差距,但需要与常规免疫系统相结合。在90.2%的国家接种了风疹疫苗,而腮腺炎疫苗的采用率仍然较低,为63.9%。非洲区域麻疹(每百万人551.8例)和风疹(每百万人21.9例)的发病率都很高。COVID-19大流行中断了疫苗接种覆盖率(全球下降3%-5%),非洲区域出现大流行后病例u型复苏。到2020年,中国向麻疹、腮腺炎和风疹疫苗的过渡使腮腺炎发病率降至百万分之100以下。结论:虽然麻疹、腮腺炎和风疹的全球控制取得了进展,但疫苗接种覆盖率的不平等和与大流行相关的干扰威胁着消除目标。加强常规免疫系统至关重要。实现世界卫生组织的2030年目标将需要对卫生系统进行持续投资并实施以公平为重点的创新。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Vaccination Status and Incidences of Measles, Mumps, and Rubella - Worldwide, 2014-2023.

Introduction: Measles, mumps, and rubella remain significant global health threats despite being vaccine-preventable diseases. The World Health Organization aims to achieve regional elimination of measles and rubella by 2030, yet substantial disparities in vaccination coverage and disease incidence persist across regions. We analyzed global vaccination and disease data to provide evidence for optimizing immunization strategies.

Methods: The study analyzed World Health Organization data on measles, mumps, and rubella from 2014-2023. Our analysis included vaccine types, recommended vaccination schedules, coverage rates, supplemental immunization activities, and disease incidence. We employed descriptive epidemiological methods for data synthesis and analysis.

Results: All countries implemented ≥1 measles-containing vaccine dose, with 190 (97.9%) countries using a ≥2-dose schedule. Global 2nd dose of measles-containing vaccine coverage increased from 59% to 74% during the study period. High-income regions maintained >90% coverage, while the African Region reported the lowest coverage (70% for the 1st dose and 49% for the 2nd dose of measles-containing vaccine). Supplemental immunization activities helped address coverage gaps but required integration with routine immunization systems. Rubella vaccine was implemented in 90.2% of countries, while mumps vaccine adoption remained lower at 63.9%. The African Region experienced high incidence rates for both measles (551.8 per million) and rubella (21.9 per million). The COVID-19 pandemic disrupted vaccination coverage (3%-5% decline globally), with the African Region experiencing a post-pandemic U-shaped resurgence in cases. China's transition to the measles, mumps, and rubella vaccine has reduced mumps incidence to below 100 cases per million by 2020.

Conclusions: While global control of measles, mumps, and rubella has progressed, inequities in vaccination coverage and pandemic-related disruptions threaten elimination goals. Strengthening routine immunization systems is critical. Achieving the World Health Organization's 2030 targets will require sustained investment in health systems and implementation of equity-focused innovations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.90
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信